Reverin 135

, , , , ,

Reverin 135

R154,00R472,00

REVERIN 135
Reg. No. G3432 (Act 36/1947)
Namibia Reg. No. V04/17.1.2/552 NS0

Long- and short acting oxytetracycline injection.

INDICATIONS
For the treatment of heartwater, tick-borne gall sickness (anaplasmosis), pneumonia, navel ill, joint ill and foot rot in stock and strangles in horses.

COMPOSITION
A sterile, stable solution of oxytetracycline. It contains the equivalent of oxytetracycline hydrochloride 135 mg/mℓ (as the magnesium complex).

DIRECTIONS FOR USE – USE ONLY AS DIRECTED
Administration

Intramuscular, subcutaneous or intravenous injection.
When injecting intramuscularly, inject into the muscle of the mid-neck area using a needle of not more than 30 mm in length.
Do not inject more than 20 mℓ at one site.
Massage the area after injection to enhance absorption and minimise swelling.
When using the intravenous route, inject slowly and pause if any discomfort is shown.
Note: The long acting dose must be administered by the intramuscular route only.

DOSAGE AND INDICATIONS: Normal Use: Horses: 8ml/100kg once daily for 3 days

DOSAGE AND INDICATIONS: Long Acting Use (When a higher efficacy and longer action are required)

N.B. For rapid recovery a prompt and accurate diagnosis is essential. It is, therefore, always advisable to consult your veterinarian for a correct diagnosis.

WARNINGS
Long- and short acting dose

Withdrawal period: Treated animals must not be slaughtered for human consumption within 28 days of last treatment. Milk from treated cows must not be used for human consumption within 7 days of treatment.

REVERIN 135
Reg. No. G3432 (Act 36/1947)
Namibia Reg. No. V04/17.1.2/552 NS0

Long- and short acting oxytetracycline injection.

INDICATIONS
For the treatment of heartwater, tick-borne gall sickness (anaplasmosis), pneumonia, navel ill, joint ill and foot rot in stock and strangles in horses.

COMPOSITION
A sterile, stable solution of oxytetracycline. It contains the equivalent of oxytetracycline hydrochloride 135 mg/mℓ (as the magnesium complex).

DIRECTIONS FOR USE – USE ONLY AS DIRECTED
Administration

Intramuscular, subcutaneous or intravenous injection.
When injecting intramuscularly, inject into the muscle of the mid-neck area using a needle of not more than 30 mm in length.
Do not inject more than 20 mℓ at one site.
Massage the area after injection to enhance absorption and minimise swelling.
When using the intravenous route, inject slowly and pause if any discomfort is shown.
Note: The long acting dose must be administered by the intramuscular route only.

DOSAGE AND INDICATIONS: Normal Use: Horses: 8ml/100kg once daily for 3 days

DOSAGE AND INDICATIONS: Long Acting Use (When a higher efficacy and longer action are required)

N.B. For rapid recovery a prompt and accurate diagnosis is essential. It is, therefore, always advisable to consult your veterinarian for a correct diagnosis.

WARNINGS
Long- and short acting dose

Withdrawal period: Treated animals must not be slaughtered for human consumption within 28 days of last treatment. Milk from treated cows must not be used for human consumption within 7 days of treatment.

Weight 0,13 kg
Dimensions 4,5 × 4,5 × 9,5 cm
Size

100 ml, 500 ml

Reviews

There are no reviews yet.

Be the first to review “Reverin 135”

Your email address will not be published. Required fields are marked *

Shopping Cart